A surgical protocol for sinogenic brain abscess: the Oxford experience and a review of the literature

Rhinology. 2022 Oct 1;60(5):357-367. doi: 10.4193/Rhin22.070.

Abstract

Background: Rhinosinusitis-induced brain abscesses are rare but can result in devastating long-term sequalae and mortality; they require a high index of suspicion with early imaging to start early empiric parenteral antibiotic treatment covering aerobes and anaerobes.

Methodology: Our study was a retrospective analysis on 32 patients who were treated at Oxford University Hospitals for rhinosinusitis-induced brain abscess between February 2013 and June 2020.

Results: Mean age of presentation was 45.83 for adults and 11.14 for children. Subdural collection was the most frequent abscess but 25% of patients had multiple sites of collection; the majority were in the frontal lobe. The most commonly identified pathogens were Streptococcus milleri group and Staphylococcus aureus; 93.75% of the patients were treated with combined Ceftriaxone and Metronidazole for an average of 8 weeks.

Conclusions: In our series most patients received also a prompt and aggressive surgical treatment with combined neurosurgical and ENT procedures in the majority; this was especially important in case of subdural empyema, Streptococcus milleri infection and direct intracranial spread of infection. More than half of the patients were treated with a single surgical procedure. Despite aggressive treatment, one third of patients experienced long-term neurological sequelae; there were no deaths.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Brain Abscess* / drug therapy
  • Brain Abscess* / surgery
  • Ceftriaxone
  • Child
  • Humans
  • Metronidazole / therapeutic use
  • Retrospective Studies
  • Review Literature as Topic
  • Sinusitis* / complications
  • Streptococcal Infections* / complications
  • Streptococcal Infections* / drug therapy

Substances

  • Anti-Bacterial Agents
  • Metronidazole
  • Ceftriaxone